CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting

por Courtney, D G, Moore, J E, Atkinson, S D, Maurizi, E, Allen, E H A, Pedrioli, D M L, McLean, W H I, Nesbit, M A, Moore, C B T
Publicado 2016